journal article·2015-11

Bioengineering vascularized tissue constructs using an injectable cell-laden enzymatically crosslinked collagen hydrogel derived from dermal extracellular matrix

Kuan-Chih Kuo, Ruei-Zeng Lin, Han-Wen Tien, Pei-Yun Wu, Yen-Cheng Li, Juan M. Melero-Martin, Ying-Chieh Chen

Acta Biomaterialia· Volume 27
Publisher page

Abstract

Tissue engineering promises to restore or replace diseased or damaged tissue by creating functional and transplantable artificial tissues. The development of artificial tissues with large dimensions that exceed the diffusion limitation will require nutrients and oxygen to be delivered via perfusion instead of diffusion alone over a short time period. One approach to perfusion is to vascularize engineered tissues, creating a de novo three-dimensional (3D) microvascular network within the tissue construct. This significantly shortens the time of in vivo anastomosis, perfusion and graft integration with the host. In this study, we aimed to develop injectable allogeneic collagen-phenolic hydroxyl (collagen-Ph) hydrogels that are capable of controlling a wide range of physicochemical properties, including stiffness, water absorption and degradability. We tested whether collagen-Ph hydrogels could support the formation of vascularized engineered tissue graft by human blood-derived endothelial colony-forming cells (ECFCs) and bone marrow-derived mesenchymal stem cells (MSC) in vivo. First, we studied the growth of adherent ECFCs and MSCs on or in the hydrogels. To examine the potential formation of functional vascular networks in vivo, a liquid pre-polymer solution of collagen-Ph containing human ECFCs and MSCs, horseradish peroxidase and hydrogen peroxide was injected into the subcutaneous space or abdominal muscle defect of an immunodeficient mouse before gelation, to form a 3D cell-laden polymerized construct. These results showed that extensive human ECFC-lined vascular networks can be generated within 7 days, the engineered vascular density inside collagen-Ph hydrogel constructs can be manipulated through refinable mechanical properties and proteolytic degradability, and these networks can form functional anastomoses with the existing vasculature to further support the survival of host muscle tissues. Finally, optimized conditions of the cell-laden collagen-Ph hydrogel resulted in not only improving the long-term differentiation of transplanted MSCs into mineralized osteoblasts, but the collagen-Ph hydrogel also improved an increased of adipocytes within the vascularized bioengineered tissue in a mouse after 1 month of implantation. Statement of significance We reported a method for preparing autologous extracellular matrix scaffolds, murine collagen-Ph hydrogels, and demonstrated its suitability for use in supporting human progenitor cell-based formation of 3D vascular networks in vitro and in vivo. Results showed extensive human vascular networks can be generated within 7 days, engineered vascular density inside collagen-Ph constructs can be manipulated through refinable mechanical properties and proteolytic degradability, and these networks can form functional anastomoses with existing vasculature to further support the survival of host muscle tissues. Moreover, optimized conditions of cell-laden collagen-Ph hydrogel resulted in not only improving the long-term differentiation of transplanted MSCs into mineralized osteoblasts, but the collagen-Ph hydrogel also improved an increased of adipocytes within the vascularized bioengineered tissue in a mouse.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Wound Healing and Treatments · 3D Printing in Biomedical Research · Collagen: Extraction and Characterization

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Engineering vascularized tissue10.1038/nbt0705-821 ↗
2. Endothelialization approaches for viable engineered tissues10.1007/s10456-012-9307-8 ↗
3. Biomaterials to prevascularize engineered tissues10.1007/s12265-011-9301-3 ↗
4. State-of-the-art tissue engineering: from tissue engineering to organ building10.1016/j.surg.2004.04.002 ↗
5. Engineering thick tissues – the vascularisation problem10.22203/eCM.v014a01 ↗
6. Vascularization strategies for tissue engineering10.1089/ten.teb.2009.0085 ↗
7. Guiding endothelial progenitor cell tube formation using patterned fibronectin surfaces10.1039/c0sm00233j ↗
8. Spatial control of cell-mediated degradation to regulate vasculogenesis and angiogenesis in hyaluronan hydrogels10.1016/j.biomaterials.2012.05.027 ↗
9. Geometrically controlled endothelial tubulogenesis in micropatterned gels10.1089/ten.tea.2009.0584 ↗
10. Directed endothelial cell morphogenesis in micropatterned gelatin methacrylate hydrogels10.1016/j.biomaterials.2012.08.068 ↗
11. Engineering vascularized skeletal muscle tissue10.1038/nbt1109 ↗
12. Human endothelial colony-forming cells serve as trophic mediators for mesenchymal stem cell engraftment via paracrine signaling10.1073/pnas.1405388111 ↗
13. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells10.1182/blood-2006-12-062471 ↗
14. Functional human vascular network generated in photocrosslinkable gelatin methacrylate hydrogels10.1002/adfm.201101662 ↗
15. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood10.1182/blood-2004-04-1396 ↗
16. Transdermal regulation of vascular network bioengineering using a photopolymerizable methacrylated gelatin hydrogel10.1016/j.biomaterials.2013.05.060 ↗
17. Adipose tissue engineering for soft tissue regeneration10.1089/ten.teb.2009.0544 ↗
18. Collagen matrix physical properties modulate endothelial colony forming cell-derived vessels in vivo10.1016/j.mvr.2010.03.001 ↗
19. Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials10.1007/s10456-012-9257-1 ↗
20. Concentrated collagen hydrogels as dermal substitutes10.1016/j.biomaterials.2009.09.073 ↗
21. Scaffolds with covalently immobilized VEGF and angiopoietin-1 for vascularization of engineered tissues10.1016/j.biomaterials.2009.09.039 ↗
22. Biomedical applications of collagen10.1016/S0378-5173(01)00691-3 ↗
23. The effect of vascular endothelial growth factor (VEGF) presentation within fibrin matrices on endothelial cell branching10.1016/j.biomaterials.2011.06.027 ↗
24. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells
25. Enzymatic regulation of functional vascular networks using gelatin hydrogels10.1016/j.actbio.2015.02.024 ↗
26. Injectable gelatin derivative hydrogels with sustained vascular endothelial growth factor release for induced angiogenesis10.1016/j.actbio.2014.11.002 ↗
27. Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices10.1182/blood-2008-12-196451 ↗
28. Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior10.1016/j.actbio.2012.08.007 ↗
29. Dense type I collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro10.1016/j.biomaterials.2010.07.072 ↗
30. Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds10.1016/j.biomaterials.2007.08.017 ↗
31. Effects of alkaline and acid pretreatments on Alaska pollock skin gelatin extraction10.1111/j.1365-2621.2005.tb11435.x ↗
32. Synthesis and characterization of both ionically and enzymatically cross-linkable alginate10.1016/j.actbio.2006.12.002 ↗
33. An injectable, in situ enzymatically gellable, gelatin derivative for drug delivery and tissue engineering10.1016/j.biomaterials.2009.03.030 ↗
34. Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release10.1182/blood-2011-08-372946 ↗
35. Bioengineering human microvascular networks in immunodeficient mice
36. Rapid onset of perfused blood vessels after implantation of ECFCs and MPCs in collagen, PuraMatrix and fibrin provisional matrices10.1002/term.1803 ↗
37. Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells10.1007/s10456-012-9272-2 ↗
38. Bioengineering human microvascular networks in immunodeficient mice
39. Fibroblast growth factor-2 facilitates rapid anastomosis formation between bioengineered human vascular networks and living vasculature10.1016/j.ymeth.2012.01.006 ↗
40. Collagen – biomaterial for drug delivery10.1016/S0939-6411(98)00017-4 ↗
41. Strategies for directing the structure and function of three-dimensional collagen biomaterials across length scales10.1016/j.actbio.2013.08.038 ↗
42. Effects of the mechanical properties of collagen gel on the in vitro formation of microvessel networks by endothelial cells10.1089/ten.2006.0333 ↗
43. Interplay of matrix stiffness and protein tethering in stem cell differentiation10.1038/nmat4051 ↗
44. The effect of substrate stiffness on adult neural stem cell behavior10.1016/j.biomaterials.2009.09.002 ↗
45. Matrix elasticity directs stem cell lineage specification10.1016/j.cell.2006.06.044 ↗
46. Degradation-mediated cellular traction directs stem cell fate in covalently crosslinked three-dimensional hydrogels10.1038/nmat3586 ↗
47. Visible light cured thiol-vinyl hydrogels with tunable degradation for 3D cell culture10.1016/j.actbio.2013.08.044 ↗
48. Biomimetic hydrogels with pro-angiogenic properties10.1016/j.biomaterials.2010.01.104 ↗
49. Creation of long-lasting blood vessels10.1038/428138a ↗
50. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering10.1016/j.biomaterials.2006.01.039 ↗
51. Osteoblast adhesion on biomaterials10.1016/S0142-9612(99)00242-2 ↗
52. Immune responses to implants – a review of the implications for the design of immunomodulatory biomaterials10.1016/j.biomaterials.2011.05.078 ↗
53. Autologous mesenchymal stem cell transplantation in stroke patients10.1002/ana.20501 ↗
54. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds10.1089/ten.2006.0278 ↗
55. Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardium10.1016/j.regpep.2003.09.005 ↗
56. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells cells for endothelialization as a potential source of autologous of silk fibroin biomaterials10.1016/j.biomaterials.2006.06.015 ↗
57. Mesenchymal stem cells: clinical applications and biological characterization10.1016/j.biocel.2003.11.001 ↗
58. Potential risks of bone marrow cell transplantation into infarcted hearts10.1182/blood-2006-12-063412 ↗
59. Vascularized bone tissue engineering: approaches for potential improvement10.1089/ten.teb.2012.0012 ↗
60. A review of the effects of the cell environment physicochemical nanoarchitecture on stem cell commitment10.1016/j.biomaterials.2014.03.044 ↗
61. Effect of BMP-2 from matrices of different stiffnesses for the modulation of stem cell fate10.1016/j.biomaterials.2012.12.007 ↗
62. Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues10.1242/jcs.079509 ↗
63. Matrigel: basement membrane matrix with biological activity10.1016/j.semcancer.2005.05.004 ↗